[Federal Register Volume 65, Number 123 (Monday, June 26, 2000)]
[Notices]
[Page 39430]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-15986]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Section 1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on May 15, 2000, Celgene 
Corporation, 7 Powder Horn Drive, Warren, New Jersey 07059, made 
application by renewal to the Drug Enforcement Administration (DEA) for 
registration as a bulk manufacturer of methylphenidate (1724) a basic 
class of controlled substance listed in Schedule II.
    The firm plans to manufacture methylphenidate for product research 
and development.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substance may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than August 25, 2000.

    Dated: June 14, 2000.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 00-15986 Filed 6-23-00; 8:45 am]
BILLING CODE 4410-09-M